M
Moses R. Kamya
Researcher at Makerere University
Publications - 504
Citations - 15407
Moses R. Kamya is an academic researcher from Makerere University. The author has contributed to research in topics: Malaria & Population. The author has an hindex of 60, co-authored 435 publications receiving 12598 citations. Previous affiliations of Moses R. Kamya include Mulago Hospital.
Papers
More filters
Journal ArticleDOI
SEARCH Human Immunodeficiency Virus (HIV) Streamlined Treatment Intervention Reduces Mortality at a Population Level in Men With Low CD4 Counts.
Moses R. Kamya,Maya L. Petersen,Jane Kabami,James Ayieko,Dalsone Kwariisima,Norton Sang,Tamara D. Clark,Joshua Schwab,Edwin D. Charlebois,Craig R. Cohen,Elizabeth A. Bukusi,James Peng,Vivek Jain,Yea-Hung Chen,Gabriel Chamie,Laura B. Balzer,Diane V. Havlir +16 more
TL;DR: In this article, the authors tested the hypothesis that patient-centered, streamlined human immunodeficiency virus (HIV) care would achieve lower mortality than the standard treatment model for persons with HIV and CD4 ≥ 350/uL in the setting of population-wide HIV testing.
Posted ContentDOI
LLIN Evaluation in Uganda Project (LLINEUP) – The durability of long-lasting insecticidal nets treated with and without piperonyl butoxide (PBO) in Uganda
Frank Mechan,Agaba Katureebe,V. Tuhaise,Martin Mugote,Ambrose Oruni,Ismail Onyige,Kawesa Bumali,Jonathan Harold Thornton,Kilama Maxwell,Mary Kyohere,Moses R. Kamya,Peter Mutungi,Simon P. Kigozi,Adoke Yeka,Jimmy Opigo,Catherine Maiteki-Sebuguzi,Sam Gonahasa,Janet Hemingway,Grant Dorsey,Lisa J. Reimer,Sarah G. Staedke,Martin O'Donnell,Amy Lynd +22 more
TL;DR: It is demonstrated that both Olyset Plus and PermaNet 3.0 are as durable as their pyrethroid-only equivalents and had superior bioefficacy against pyrethoid-resistant An.
Journal ArticleDOI
House design and risk of malaria, acute respiratory infection and gastrointestinal illness in Uganda: A cohort study
Alex K. Musiime,Paul J. Krezanoski,David L. Smith,Maxwell Kilama,Melissa D. Conrad,Geoffrey Otto,Patrick Kyagamba,John Baptist Asiimwe,John Rek,Joaniter I. Nankabirwa,Emmanuel Arinaitwe,Anne M. Akol,Moses R. Kamya,Sarah G. Staedke,Chris Drakeley,Teun Bousema,Steve W. Lindsay,Grant Dorsey,Lucy S. Tusting +18 more
TL;DR: Improvements to housing would be associated with reductions in malaria, acute respiratory infection (ARI) and gastrointestinal illness in an area of low malaria endemicity in Uganda, and modern houses were associated with a 53% lower human biting rate compared to traditional houses.
Journal ArticleDOI
Changes in the Timing of Antiretroviral Therapy Initiation in HIV-Infected Patients With Tuberculosis in Uganda: A Study of the Diffusion of Evidence Into Practice in the Global Response to HIV/AIDS
Tara Vijayan,Fred C. Semitala,Nicholas Matsiko,Patrick Elyanu,Jennifer Namusobya,Diane V. Havlir,Moses R. Kamya,Elvin Geng +7 more
TL;DR: Large changes in clinical practice are observed during a period of emerging data and changing guidelines among HIV-infected patients with tuberculosis, with a significant proportion of individuals with higher CD4 cell counts do not start ART within recommended time frames.
Journal ArticleDOI
Characteristics of HIV seroconverters in the setting of universal test and treat: Results from the SEARCH trial in rural Uganda and Kenya.
Marilyn Nyabuti,Maya L. Petersen,Elizabeth A. Bukusi,Moses R. Kamya,Florence Mwangwa,Jane Kabami,Norton Sang,Edwin D. Charlebois,Laura B. Balzer,Joshua Schwab,Carol S. Camlin,Douglas Black,Tamara D. Clark,Gabriel Chamie,Diane V. Havlir,James Ayieko +15 more
TL;DR: Nyabuti et al. as mentioned in this paper characterized seroconverters and risk factors in the SEARCH UTT trial, which achieved high uptake of universal HIV testing and ART coverage in 32 communities of adults (≥15 years) in rural Uganda and Kenya.